AMERICA KAISUM SCI-TECH DEVELOPMENT CO.,LIMITED – Trademark Portfolio

Entity Type: 99

AMERICA KAISUM SCI-TECH DEVELOPMENT CO.,LIMITED holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include GDG. The owner is based in KWUN TONG KL.

UNIT 1507B,15/F,EASTCORE,

398 KWUN TONG ROAD

KWUN TONG KL 999077 , HK

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

GDG
GDG
Registered 2020

Trademark Classifications

AMERICA KAISUM SCI-TECH DEVELOPMENT CO.,LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does AMERICA KAISUM SCI-TECH DEVELOPMENT CO.,LIMITED have?

AMERICA KAISUM SCI-TECH DEVELOPMENT CO.,LIMITED has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does AMERICA KAISUM SCI-TECH DEVELOPMENT CO.,LIMITED file in?

AMERICA KAISUM SCI-TECH DEVELOPMENT CO.,LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are AMERICA KAISUM SCI-TECH DEVELOPMENT CO.,LIMITED's most well-known trademarks?

AMERICA KAISUM SCI-TECH DEVELOPMENT CO.,LIMITED's registered trademark portfolio includes well-known marks such as GDG. These are among 1 currently registered trademark in the portfolio.

What is AMERICA KAISUM SCI-TECH DEVELOPMENT CO.,LIMITED's trademark registration success rate?

AMERICA KAISUM SCI-TECH DEVELOPMENT CO.,LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.